The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Perindopril arginine/amlodipine TAD 5 mg/10 mg tablets



TAD Pharma GmbHPA0876/012/002

Main Information

Trade NamePerindopril arginine/amlodipine TAD 5 mg/10 mg tablets
Active SubstancesPerindopril arginine
Amlodipine
Dosage FormTablet
Licence HolderTAD Pharma GmbH
Licence NumberPA0876/012/002

Group Information

ATC CodeC09BB04 perindopril and amlodipine

Status

License statusAuthorised
Licence Issued14/04/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back